375 related articles for article (PubMed ID: 25776560)
1. Cell regulation by phosphotyrosine-targeted ubiquitin ligases.
Cooper JA; Kaneko T; Li SS
Mol Cell Biol; 2015 Jun; 35(11):1886-97. PubMed ID: 25776560
[TBL] [Abstract][Full Text] [Related]
2. E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis.
Sévère N; Dieudonné FX; Marie PJ
Cell Death Dis; 2013 Jan; 4(1):e463. PubMed ID: 23328670
[TBL] [Abstract][Full Text] [Related]
3. A CSF-1 receptor phosphotyrosine 559 signaling pathway regulates receptor ubiquitination and tyrosine phosphorylation.
Xiong Y; Song D; Cai Y; Yu W; Yeung YG; Stanley ER
J Biol Chem; 2011 Jan; 286(2):952-60. PubMed ID: 21041311
[TBL] [Abstract][Full Text] [Related]
4. The Cbl family: ubiquitin ligases regulating signaling by tyrosine kinases.
Sanjay A; Horne WC; Baron R
Sci STKE; 2001 Nov; 2001(110):pe40. PubMed ID: 11724969
[TBL] [Abstract][Full Text] [Related]
5. Negative regulation of Lck by Cbl ubiquitin ligase.
Rao N; Miyake S; Reddi AL; Douillard P; Ghosh AK; Dodge IL; Zhou P; Fernandes ND; Band H
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3794-9. PubMed ID: 11904433
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of signaling through the B cell antigen receptor by the protooncogene product, c-Cbl, requires Syk tyrosine 317 and the c-Cbl phosphotyrosine-binding domain.
Yankee TM; Keshvara LM; Sawasdikosol S; Harrison ML; Geahlen RL
J Immunol; 1999 Dec; 163(11):5827-35. PubMed ID: 10570266
[TBL] [Abstract][Full Text] [Related]
7. Cbl-mediated ubiquitination of alpha5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation.
Kaabeche K; Guenou H; Bouvard D; Didelot N; Listrat A; Marie PJ
J Cell Sci; 2005 Mar; 118(Pt 6):1223-32. PubMed ID: 15728256
[TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases.
Mohapatra B; Ahmad G; Nadeau S; Zutshi N; An W; Scheffe S; Dong L; Feng D; Goetz B; Arya P; Bailey TA; Palermo N; Borgstahl GE; Natarajan A; Raja SM; Naramura M; Band V; Band H
Biochim Biophys Acta; 2013 Jan; 1833(1):122-39. PubMed ID: 23085373
[TBL] [Abstract][Full Text] [Related]
9. New Insights into the Role of Ubiquitin Networks in the Regulation of Antiapoptosis Pathways.
Asaoka T; Ikeda F
Int Rev Cell Mol Biol; 2015; 318():121-58. PubMed ID: 26315885
[TBL] [Abstract][Full Text] [Related]
10. Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation.
Kim M; Tezuka T; Tanaka K; Yamamoto T
Oncogene; 2004 Mar; 23(9):1645-55. PubMed ID: 14661060
[TBL] [Abstract][Full Text] [Related]
11. Negative regulation of receptor tyrosine kinases by ubiquitination: Key roles of the Cbl family of E3 ubiquitin ligases.
Tang R; Langdon WY; Zhang J
Front Endocrinol (Lausanne); 2022; 13():971162. PubMed ID: 35966060
[TBL] [Abstract][Full Text] [Related]
12. c-Cbl is a negative regulator of GH-stimulated STAT5-mediated transcription.
Goh EL; Zhu T; Leong WY; Lobie PE
Endocrinology; 2002 Sep; 143(9):3590-603. PubMed ID: 12193575
[TBL] [Abstract][Full Text] [Related]
13. The Cbl family of ubiquitin ligases: critical negative regulators of tyrosine kinase signaling in the immune system.
Rao N; Dodge I; Band H
J Leukoc Biol; 2002 May; 71(5):753-63. PubMed ID: 11994499
[TBL] [Abstract][Full Text] [Related]
14. Targeting neddylation in cancer therapy.
Duncan K; Schäfer G; Vava A; Parker MI; Zerbini LF
Future Oncol; 2012 Nov; 8(11):1461-70. PubMed ID: 23148618
[TBL] [Abstract][Full Text] [Related]
15. E3 ubiquitin ligases as cancer targets and biomarkers.
Sun Y
Neoplasia; 2006 Aug; 8(8):645-54. PubMed ID: 16925947
[TBL] [Abstract][Full Text] [Related]
16. Membrane-anchored Cbl suppresses Hck protein-tyrosine kinase mediated cellular transformation.
Howlett CJ; Robbins SM
Oncogene; 2002 Mar; 21(11):1707-16. PubMed ID: 11896602
[TBL] [Abstract][Full Text] [Related]
17. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
Bowtell DD; Langdon WY
Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
[TBL] [Abstract][Full Text] [Related]
18. Cullin 5-RING E3 ubiquitin ligases, new therapeutic targets?
Lamsoul I; Uttenweiler-Joseph S; Moog-Lutz C; Lutz PG
Biochimie; 2016 Mar; 122():339-47. PubMed ID: 26253693
[TBL] [Abstract][Full Text] [Related]
19. Novel RING E3 ubiquitin ligases in breast cancer.
Burger A; Amemiya Y; Kitching R; Seth AK
Neoplasia; 2006 Aug; 8(8):689-95. PubMed ID: 16925951
[TBL] [Abstract][Full Text] [Related]
20. Regulation of autophagy by E3 ubiquitin ligase RNF216 through BECN1 ubiquitination.
Xu C; Feng K; Zhao X; Huang S; Cheng Y; Qian L; Wang Y; Sun H; Jin M; Chuang TH; Zhang Y
Autophagy; 2014; 10(12):2239-50. PubMed ID: 25484083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
